Circulars
Pharmacy Circular 001/23 Cariban
Published: January 2023
Updated: April 2026
Documents
Pharmacy Circular 001/23 Cariban
PDF, 670KB, 4 pages
Summary
Pharmacy Circular 001/23 – Cariban, published on 4 January 2023, informs community pharmacists of the inclusion of Cariban® (doxylamine/pyridoxine modified-release capsules) under HSE reimbursement arrangements for the management of nausea and vomiting in pregnancy, outlining prescribing requirements, eligibility criteria, and dispensing and payment procedures under the community drug schemes.
This is a beta version - your feedback will help us to improve it